Emergency Medicine AccessConfirmed
FDA Extended the Only U.S.-Licensed Coral Snake Antivenin Lot
FDA extended one North American coral snake antivenin lot through December 31, 2026, highlighting an emergency-medicine supply chain held together by stability data.
Why now
The extension keeps a critical emergency product available in the absence of a licensed U.S. alternative.
- Overclaim risk
- medium
- Primary source
- Official
- Published
- Jul 5, 2026